Investing.com - Financial Markets Worldwide

Harbin Pharmaceutical Group Co Ltd (600664)

Shanghai
Currency in CNY
3.92
0.00(0.00%)
Delayed Data·
600664 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
600664 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
3.913.94
52 wk Range
2.904.97
Key Statistics
Edit
Bid/Ask
3.92 / 3.93
Prev. Close
3.92
Open
3.92
Day's Range
3.91-3.94
52 wk Range
2.9-4.97
Volume
5.7M
Average Volume (3m)
55.07M
1-Year Change
20.25%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600664 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Strong Buy
Price Target
4.95
Upside
+26.28%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
High shareholder yield
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Harbin Pharmaceutical Group Co Ltd Company Profile

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cerebrovascular, and cardiovascular diseases, as well as mineral and nutritional supplements, Chinese medicines, and antibiotics. It also provides calcium iron zinc oral solutions, zinc gluconate oral solutions, compound calcium gluconate oral solutions, Shuanghuanglian oral solutions, amoxicillin capsules, recombinant human erythropoietin injections, ibuprofen granules, iron vitamin B12 oral solutions, ceftriaxone sodium injections, pediatric acetaminophen granules, Jiananxi Vitapak nutrition packages, lacidipine tablets, roxatidine acetate hydrochloride for injections, and penicillin and cephalosporin antibiotic preparations. The company sells its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. It is also involved in culture, science and technology, passenger transport, food, property, security, and pharmaceutical investment services, as well as biology and health technology activities. Harbin Pharmaceutical Group Co., Ltd. was founded in 1991 and is based in Harbin, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
10180
Market
China

Compare 600664 to Peers and Sector

Metrics to compare
600664
Peers
Sector
Relationship
P/E Ratio
14.8x14.5x−0.5x
PEG Ratio
0.330.140.00
Price/Book
1.8x2.6x2.6x
Price / LTM Sales
0.6x3.2x3.3x
Upside (Analyst Target)
26.3%12.6%43.3%
Fair Value Upside
Unlock−0.7%6.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.95
(+26.28% Upside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.08 / --
Revenue / Forecast
4.17B / --
EPS Revisions
a
a
Unlock
Last 90 days

600664 Income Statement

FAQ

What Stock Exchange Does Harbin Pharm Trade On?

Harbin Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Harbin Pharm?

The stock symbol for Harbin Pharm is "600664."

What Is the Harbin Pharm Market Cap?

As of today, Harbin Pharm market cap is 9.87B.

What Is Harbin Pharm's Earnings Per Share (TTM)?

The Harbin Pharm EPS (TTM) is 0.26.

When Is the Next Harbin Pharm Earnings Date?

Harbin Pharm will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 600664 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Harbin Pharm Stock Split?

Harbin Pharm has split 6 times.

How Many Employees Does Harbin Pharm Have?

Harbin Pharm has 10180 employees.

What is the current trading status of Harbin Pharm (600664)?

As of 11 Aug 2025, Harbin Pharm (600664) is trading at a price of 3.92, with a previous close of 3.92. The stock has fluctuated within a day range of 3.91 to 3.94, while its 52-week range spans from 2.90 to 4.97.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.